Company news
Heidelberg Pharma Ag (XETR:HPHA) news
Every Heidelberg Pharma Ag press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2026
June 23, 2026
Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2026
April 29, 2026
Heidelberg Pharma Announces Change in Executive Board
April 17, 2026
Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101
April 9, 2026
Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
April 4, 2026
Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
March 26, 2026
Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
March 18, 2026
Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Bo...
November 24, 2025
Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar
November 3, 2025
Heidelberg Pharma to Present at the Life Sciences Virtual Investor Forum June 12th
June 6, 2025